Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 35 | 2024 | 5097 | 2.850 |
Why?
|
| Reproductive Health Services | 6 | 2024 | 66 | 2.170 |
Why?
|
| Sexual Partners | 14 | 2024 | 215 | 1.790 |
Why?
|
| Health Personnel | 12 | 2023 | 231 | 1.770 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2020 | 262 | 1.550 |
Why?
|
| Family Planning Services | 9 | 2023 | 46 | 1.550 |
Why?
|
| Sexual Behavior | 8 | 2020 | 320 | 1.440 |
Why?
|
| Reproductive Health | 6 | 2024 | 51 | 1.340 |
Why?
|
| Female | 45 | 2024 | 9103 | 1.210 |
Why?
|
| South Africa | 43 | 2024 | 7596 | 1.180 |
Why?
|
| Humans | 55 | 2024 | 14537 | 1.130 |
Why?
|
| Male | 34 | 2024 | 6754 | 1.110 |
Why?
|
| Qualitative Research | 11 | 2024 | 321 | 1.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 112 | 1.010 |
Why?
|
| Contraception Behavior | 7 | 2023 | 54 | 1.010 |
Why?
|
| Health Services Accessibility | 4 | 2024 | 280 | 0.980 |
Why?
|
| Adult | 28 | 2024 | 5913 | 0.970 |
Why?
|
| Premature Birth | 2 | 2023 | 80 | 0.950 |
Why?
|
| Circumcision, Male | 4 | 2018 | 99 | 0.930 |
Why?
|
| Harm Reduction | 1 | 2024 | 7 | 0.910 |
Why?
|
| Contraceptive Devices, Female | 2 | 2024 | 30 | 0.910 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2024 | 11 | 0.900 |
Why?
|
| Social Stigma | 2 | 2024 | 80 | 0.900 |
Why?
|
| Pyrimidines | 1 | 2024 | 32 | 0.890 |
Why?
|
| Contraception | 12 | 2023 | 90 | 0.870 |
Why?
|
| Sexual Health | 2 | 2024 | 14 | 0.830 |
Why?
|
| Focus Groups | 15 | 2024 | 196 | 0.810 |
Why?
|
| Epidemics | 1 | 2023 | 65 | 0.790 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2018 | 33 | 0.780 |
Why?
|
| Pregnancy | 18 | 2024 | 1862 | 0.700 |
Why?
|
| Community Participation | 5 | 2021 | 42 | 0.690 |
Why?
|
| Lubrication | 1 | 2020 | 3 | 0.680 |
Why?
|
| Middle Aged | 13 | 2024 | 3601 | 0.670 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 106 | 0.660 |
Why?
|
| HIV | 3 | 2018 | 380 | 0.660 |
Why?
|
| Vagina | 1 | 2020 | 91 | 0.650 |
Why?
|
| Contraceptive Agents | 5 | 2023 | 27 | 0.630 |
Why?
|
| Adolescent | 19 | 2024 | 2985 | 0.620 |
Why?
|
| Counseling | 9 | 2023 | 143 | 0.600 |
Why?
|
| Mass Screening | 1 | 2020 | 245 | 0.590 |
Why?
|
| Young Adult | 18 | 2024 | 2498 | 0.530 |
Why?
|
| Pre-Exposure Prophylaxis | 5 | 2023 | 196 | 0.480 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2024 | 256 | 0.460 |
Why?
|
| Public Sector | 3 | 2023 | 82 | 0.410 |
Why?
|
| Interviews as Topic | 6 | 2024 | 203 | 0.410 |
Why?
|
| Device Removal | 2 | 2024 | 14 | 0.410 |
Why?
|
| AIDS Vaccines | 4 | 2006 | 152 | 0.380 |
Why?
|
| Preventive Health Services | 1 | 2011 | 17 | 0.380 |
Why?
|
| Men | 3 | 2021 | 15 | 0.370 |
Why?
|
| Contraceptive Agents, Female | 2 | 2023 | 47 | 0.370 |
Why?
|
| Condoms, Female | 3 | 2020 | 41 | 0.360 |
Why?
|
| Anti-HIV Agents | 3 | 2024 | 1324 | 0.340 |
Why?
|
| Kenya | 4 | 2024 | 183 | 0.320 |
Why?
|
| Research Subjects | 2 | 2005 | 4 | 0.310 |
Why?
|
| Choice Behavior | 2 | 2021 | 16 | 0.310 |
Why?
|
| Uganda | 3 | 2024 | 197 | 0.280 |
Why?
|
| Zambia | 6 | 2023 | 115 | 0.280 |
Why?
|
| Sex Counseling | 3 | 2016 | 9 | 0.270 |
Why?
|
| Safe Sex | 4 | 2021 | 68 | 0.270 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2019 | 103 | 0.260 |
Why?
|
| Feasibility Studies | 2 | 2024 | 101 | 0.260 |
Why?
|
| Ethics Committees, Research | 1 | 2006 | 5 | 0.260 |
Why?
|
| Women | 2 | 2017 | 12 | 0.250 |
Why?
|
| Ethics, Research | 1 | 2005 | 6 | 0.250 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 1422 | 0.240 |
Why?
|
| Circumcision, Female | 1 | 2024 | 1 | 0.230 |
Why?
|
| Needle-Exchange Programs | 1 | 2024 | 3 | 0.230 |
Why?
|
| Surveys and Questionnaires | 6 | 2023 | 563 | 0.230 |
Why?
|
| Aged | 3 | 2020 | 1740 | 0.220 |
Why?
|
| Pregnant Women | 2 | 2022 | 89 | 0.220 |
Why?
|
| Risk-Taking | 4 | 2020 | 121 | 0.220 |
Why?
|
| Self Report | 1 | 2024 | 114 | 0.220 |
Why?
|
| Emotions | 1 | 2023 | 18 | 0.210 |
Why?
|
| Drug Users | 1 | 2023 | 3 | 0.210 |
Why?
|
| HIV Seropositivity | 4 | 2020 | 265 | 0.210 |
Why?
|
| Prenatal Care | 1 | 2024 | 147 | 0.200 |
Why?
|
| Hepatitis C | 1 | 2023 | 37 | 0.200 |
Why?
|
| Cultural Characteristics | 3 | 2013 | 15 | 0.200 |
Why?
|
| Obstetric Labor, Premature | 1 | 2022 | 6 | 0.200 |
Why?
|
| Intrauterine Devices, Copper | 1 | 2023 | 20 | 0.200 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2016 | 529 | 0.190 |
Why?
|
| Infant, Newborn | 2 | 2023 | 1479 | 0.190 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2016 | 472 | 0.190 |
Why?
|
| Disclosure | 1 | 2021 | 25 | 0.180 |
Why?
|
| Fertility | 1 | 2021 | 22 | 0.180 |
Why?
|
| Pregnancy, Unplanned | 1 | 2021 | 19 | 0.180 |
Why?
|
| Desogestrel | 1 | 2021 | 2 | 0.180 |
Why?
|
| Income | 1 | 2021 | 85 | 0.180 |
Why?
|
| Intention | 1 | 2021 | 23 | 0.180 |
Why?
|
| Risk Factors | 2 | 2020 | 1475 | 0.180 |
Why?
|
| Patient Preference | 1 | 2021 | 30 | 0.180 |
Why?
|
| Stakeholder Participation | 1 | 2020 | 9 | 0.170 |
Why?
|
| Retreatment | 1 | 2020 | 6 | 0.170 |
Why?
|
| Condoms | 3 | 2021 | 88 | 0.170 |
Why?
|
| Adolescent Behavior | 2 | 2014 | 60 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 111 | 0.170 |
Why?
|
| Vaginal Creams, Foams, and Jellies | 1 | 2019 | 24 | 0.160 |
Why?
|
| Needs Assessment | 1 | 2019 | 29 | 0.160 |
Why?
|
| Fertilization | 2 | 2021 | 22 | 0.160 |
Why?
|
| Child | 3 | 2022 | 2242 | 0.160 |
Why?
|
| Communication Barriers | 2 | 2020 | 10 | 0.160 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 468 | 0.150 |
Why?
|
| Interpersonal Relations | 3 | 2017 | 43 | 0.150 |
Why?
|
| Community Health Services | 1 | 2018 | 58 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 43 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 252 | 0.140 |
Why?
|
| Health Risk Behaviors | 1 | 2017 | 7 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 3 | 2021 | 551 | 0.140 |
Why?
|
| Infant | 1 | 2023 | 2244 | 0.140 |
Why?
|
| Self Administration | 1 | 2016 | 5 | 0.130 |
Why?
|
| Health Policy | 2 | 2020 | 140 | 0.130 |
Why?
|
| AIDS Serodiagnosis | 1 | 2016 | 44 | 0.130 |
Why?
|
| Guidelines as Topic | 2 | 2006 | 40 | 0.120 |
Why?
|
| Nurse Administrators | 1 | 2015 | 9 | 0.120 |
Why?
|
| Primary Prevention | 2 | 2013 | 27 | 0.120 |
Why?
|
| Nurses | 1 | 2015 | 32 | 0.120 |
Why?
|
| Pregnancy in Adolescence | 1 | 2014 | 15 | 0.110 |
Why?
|
| Chemoprevention | 1 | 2014 | 33 | 0.110 |
Why?
|
| Sex Education | 3 | 2020 | 17 | 0.110 |
Why?
|
| Gender Identity | 2 | 2011 | 23 | 0.100 |
Why?
|
| Sexuality | 1 | 2012 | 11 | 0.100 |
Why?
|
| Public Opinion | 1 | 2011 | 6 | 0.100 |
Why?
|
| Policy Making | 1 | 2011 | 32 | 0.090 |
Why?
|
| Pandemics | 2 | 2023 | 296 | 0.090 |
Why?
|
| Reproductive Medicine | 1 | 2010 | 4 | 0.090 |
Why?
|
| Administration, Intravaginal | 2 | 2021 | 50 | 0.090 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2010 | 9 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 33 | 0.080 |
Why?
|
| Decision Making | 2 | 2011 | 53 | 0.080 |
Why?
|
| Norethindrone | 1 | 2010 | 26 | 0.080 |
Why?
|
| Withholding Treatment | 1 | 2010 | 26 | 0.080 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2010 | 44 | 0.080 |
Why?
|
| Role | 1 | 2009 | 4 | 0.080 |
Why?
|
| Weight Gain | 1 | 2010 | 77 | 0.080 |
Why?
|
| India | 1 | 2009 | 62 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2009 | 225 | 0.070 |
Why?
|
| Comprehension | 1 | 2006 | 5 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2019 | 89 | 0.070 |
Why?
|
| Informed Consent | 1 | 2006 | 8 | 0.070 |
Why?
|
| Health Services Needs and Demand | 2 | 2019 | 57 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 435 | 0.070 |
Why?
|
| Committee Membership | 1 | 2006 | 1 | 0.060 |
Why?
|
| Ethical Review | 1 | 2006 | 2 | 0.060 |
Why?
|
| Financial Support | 1 | 2006 | 10 | 0.060 |
Why?
|
| Zimbabwe | 2 | 2021 | 120 | 0.060 |
Why?
|
| Child Behavior | 1 | 2005 | 11 | 0.060 |
Why?
|
| Patient Selection | 1 | 2005 | 40 | 0.060 |
Why?
|
| Africa | 1 | 2006 | 376 | 0.060 |
Why?
|
| Somalia | 1 | 2024 | 2 | 0.060 |
Why?
|
| Guinea | 1 | 2024 | 6 | 0.060 |
Why?
|
| Communication | 1 | 2024 | 57 | 0.050 |
Why?
|
| Intrauterine Devices | 1 | 2023 | 9 | 0.050 |
Why?
|
| Attitude to Health | 2 | 2014 | 56 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2023 | 37 | 0.050 |
Why?
|
| Standard of Care | 1 | 2023 | 30 | 0.050 |
Why?
|
| Levonorgestrel | 1 | 2023 | 17 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 125 | 0.050 |
Why?
|
| Prevalence | 2 | 2017 | 1192 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2021 | 62 | 0.050 |
Why?
|
| Contraceptive Devices | 1 | 2021 | 3 | 0.050 |
Why?
|
| Disease Transmission, Infectious | 1 | 2021 | 39 | 0.040 |
Why?
|
| Trust | 1 | 2020 | 9 | 0.040 |
Why?
|
| Social Responsibility | 1 | 2020 | 12 | 0.040 |
Why?
|
| Private Sector | 1 | 2020 | 45 | 0.040 |
Why?
|
| Coitus | 1 | 2019 | 15 | 0.040 |
Why?
|
| National Health Programs | 1 | 2020 | 78 | 0.040 |
Why?
|
| Medical Assistance | 1 | 2018 | 8 | 0.040 |
Why?
|
| Abortion, Induced | 1 | 2018 | 16 | 0.040 |
Why?
|
| Government Programs | 1 | 2018 | 30 | 0.040 |
Why?
|
| Heterosexuality | 1 | 2018 | 30 | 0.040 |
Why?
|
| Physicians | 1 | 2018 | 31 | 0.040 |
Why?
|
| Community Health Workers | 1 | 2018 | 66 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2019 | 889 | 0.030 |
Why?
|
| Home Nursing | 1 | 2016 | 8 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 127 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 411 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 685 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 239 | 0.030 |
Why?
|
| Women's Health Services | 1 | 2014 | 12 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 87 | 0.030 |
Why?
|
| Pregnancy, Unwanted | 1 | 2011 | 9 | 0.020 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2010 | 20 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2010 | 48 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2010 | 57 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 111 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 244 | 0.020 |
Why?
|
| Public Health | 1 | 2010 | 124 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 321 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2010 | 1160 | 0.020 |
Why?
|
| Data Collection | 1 | 2006 | 86 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2006 | 179 | 0.020 |
Why?
|
| Bioethical Issues | 1 | 2005 | 4 | 0.020 |
Why?
|
| Peer Group | 1 | 2005 | 14 | 0.020 |
Why?
|
| Family Relations | 1 | 2005 | 7 | 0.020 |
Why?
|
| Health Behavior | 1 | 2005 | 79 | 0.010 |
Why?
|